InvoSurg is a medical utility app for cardiac surgery clinicians and perfusionists, providing clinical calculators and evidence-based guidelines on iOS.
The App DNA
What makes this app unique?
Clinicians need immediate access to cardiopulmonary bypass calculations and ECLS guidelines during high-stakes procedures, which InvoSurg provides without the friction of searching external databases.
For Clinicians and perfusionists working in cardiac surgery and extra corporeal life support.
What does it look like?
Key features
Calculates Delivered Oxygen during cardiopulmonary bypass procedures, acting as a B2B distribution barrier for cardiac surgery departments.
Centralizes evidence-based guidelines and publications on CPB and ECLS to drive daily professional utility.
Provides operational value to hospital administrators, increasing institutional adoption.
How much does it cost?
InvoSurg operates as a free professional utility, serving as a brand-building and recruitment funnel for InvoSurg, Inc.
Velocity
Dormant developmentnew contentUX improvementsShow more...
InvoSurg has been inactive for 978 days, indicating a complete cessation of development. The latest release, which introduced resource consolidation and new calculator tools, remains the only version in the observed window. There is no evidence of ongoing maintenance or feature updates, marking the app as a zombie project.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for InvoSurg
How's the Medical market?
InvoSurg occupies a niche professional segment within the Medical category, relying on specialized clinical utility rather than broad consumer appeal. The absence of recent updates (978 days since last store update) signals a lack of competitive pressure in this specific clinical workflow segment.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for InvoSurg
Where is it heading?
The outlook for InvoSurg is declining as the product remains in a maintenance-only state without updates to its core clinical content. In a medical context, the inability to provide current, evidence-based guidelines will inevitably lead to user churn as clinicians migrate to more reliable, frequently updated digital resources.
- The 978-day update gap indicates a zombie development state, which erodes user trust in the accuracy of clinical guidelines.
- Static, unmaintained resource libraries are increasingly vulnerable to more current, web-based clinical alternatives that provide real-time updates.
The SWOT
- Specialized clinical utility (DO2 calculator) functions as a B2B distribution barrier into cardiac surgery departments.
- Integration of real-time clinical data feeds could differentiate InvoSurg from static, document-based competitors.
Next best moves
Audit clinical guidelines for accuracy because the 32-month update gap risks providing outdated medical information to clinicians → maintain professional credibility.
+ 1 more prioritized moveThe counter-intuitive read
The lack of updates is not just a neglect issue…
Read the full takeBottom line
InvoSurg provides specialized clinical value, but the 32-month development silence undermines its reliability as a medical reference tool. Addressing the clinical accuracy of the existing library would restore trust, but the lack of active development suggests the product is no longer a priority for the developer.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated